The role of radiotherapy in salivary gland neoplasms

The role of radiation in the treatment of carcinoma of the salivary glands is expanding. It has a definite role in controlling the primary tumor, particularly in those postoperative cases with microscopic residua in the surgical field. Radiotherapy also plays a significant role in controlling the primary tumor in carcinomas that are inoperable or have recurred after surgery. The doses employed must be high (between 6000 and 7000 rads, given over six to seven weeks). The complications are tolerable and depend upon the area irradiated.